Ausgabe 10/2019
Inhalt (18 Artikel)
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
J. Gao, H.-R. Li, C. Jin, J.-H. Jiang, J.-Y. Ding
Recommendations for follow-up of colorectal cancer survivors
R. Vera, J. Aparicio, F. Carballo, M. Esteva, E. González-Flores, J. Santianes, F. Santolaya, J. M. Fernández-Cebrián
Expression of PDK1 in malignant pheochromocytoma as a new promising potential therapeutic target
X. Zhang, Z. Yu
Results of a nationwide survey on multidisciplinary teams on thyroid cancer in Spain
J. J. Díez, J. C. Galofré, A. Oleaga, E. Grande, M. Mitjavila, P. Moreno
Seven genes for the prognostic prediction in patients with glioma
G.-H. Zhang, Q.-Y. Zhong, X.-X. Gou, E.-X. Fan, Y. Shuai, M.-N. Wu, G.-J. Yue
Multiple sclerosis outcomes after cancer immunotherapy
Catherine R. Garcia, Rani Jayswal, Val Adams, Lowell B. Anthony, John L. Villano
The detection and clinical significance of peripheral regulatory CD4+CD25hiCD127low T cells in patients with non-small cell lung cancer
J. Qiu, G. Che, F. Liu, X. Sha, S. Ju, H. Ma, L. Feng
Mitotic rate as an important prognostic factor in cutaneous malignant melanoma
A. Piñero-Madrona, G. Ruiz-Merino, P. Cerezuela Fuentes, E. Martínez-Barba, J. N. Rodríguez-López, J. Cabezas-Herrera
The use of cisplatin plus doxorubicin or paclitaxel in hyperthermic intraperitoneal chemotherapy (HIPEC) for stage IIIC or IV epithelial ovarian cancer: a comparative study
I. Manzanedo, F. Pereira, Á. Serrano, E. Pérez-Viejo, B. Martínez-Torres, L. Carrión, J. Calzas
A comprehensive analysis of factors related to carmustine/bevacizumab response in recurrent glioblastoma
A. F. Cardona, L. Rojas, B. Wills, A. Ruiz-Patiño, L. Abril, F. Hakim, E. Jiménez, N. Useche, S. Bermúdez, J. A. Mejía, J. F. Ramón, H. Carranza, C. Vargas, J. Otero, P. Archila, J. Rodríguez, J. Rodríguez, J. Behaine, D. González, J. Jacobo, H. Cifuentes, O. Feo, P. Penagos, D. Pineda, L. Ricaurte, L. E. Pino, C. Vargas, J. C. Marquez, M. I. Mantilla, L. D. Ortiz, C. Balaña, R. Rosell, Z. L. Zatarain-Barrón, O. Arrieta
Prognostic factors and survival in Ewing’s sarcoma treated by limb salvage surgery
J. Alvarez-SanNicolas, I. Gracia-Alegria, L. Trullols-Tarrago, A. Peiro-Ibañez, C. Lamas-Gomez
Added value of diffusion-weighted MRI for nodal radiotherapy planning in pelvic malignancies
N. Sushentsev, H. Martin, Y. Rimmer, T. Barrett
Comparison of overall survival and quality of life between patients undergoing anal reconstruction and patients undergoing traditional lower abdominal stoma after radical resection
P. Du, S.-Y. Wang, P.-F. Zheng, J. Mao, H. Hu, Z.-B. Cheng
Evidence mapping based on systematic reviews of therapeutic interventions for soft tissue sarcomas
M. Ballesteros, N. Montero, A. López-Pousa, G. Urrútia, I. Solà, G. Rada, H. Pardo-Hernandez, X. Bonfill
Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab
R. A. Manneh Kopp, J. M. Sepúlveda-Sánchez, Y. Ruano, O. Toldos, A. Pérez Núñez, D. Cantero, A. Hilario, A. Ramos, G. de Velasco, P. Sánchez-Gómez, A. Hernández-Laín
Data from real world to evaluate the efficacy of osimertinib in non-small cell lung cancer patients with central nervous system metastasis
P. Xing, Y. Mu, X. Hao, Y. Wang, J. Li
ΔNp73 status in peritoneal and ovarian dissemination of appendicular adenocarcinoids (goblet cells)
M. I. Prieto-Nieto, D. Pastor, J. Rodríguez-Cobos, J. P. Pérez, C. Méndez, E. Palacios, M. Arranz-Alvarez, J. Santos-López, M. Cano-Vega, D. Viñal, N. Rodríguez, G. Domínguez
Correction to: Recommendations for follow‑up of colorectal cancer survivors
R. Vera, J. Aparicio, F. Carballo, M. Esteva, E. González-Flores, J. Santianes, F. Santolaya, J. M. Fernández-Cebrián